2022 NIAID Omnibus Broad Agency Announcement

Closed Solicitation Posted Jan 18, 2022

This opportunity was awarded. See its 4 award notices in the notice history.

Solicitation number: HHS-NIH-NIAID-BAA2022-1
Agency: National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Responses due: Apr 18, 2022, 3:00 PM ET
Set-aside: No set-aside

Opportunity facts

NAICS code: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research

Notice details come from SAM.gov. Updated Apr 8, 2022.

About this opportunity

Written by GovTribe AI · Dec 29, 2023

This Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases solicits proposals across four research areas seeking the development of vaccine candidates, therapeutic candidates, antiviral drugs targeting specific RNA viruses, and in vitro diagnostics. Proposals are due April 18, 2022 for research areas one, two and four, and March 18, 2022 for area three focusing on antiviral development. Evaluation will be based on technical merit, qualifications of the offeror, and reasonableness of estimated costs.

There is no set-aside designated. Research and development is the primary NAICS and PSC codes. The total estimated budget for FY2023 is up to $12.8 million for research areas one, two, and four to be divided among multiple awards, and up to $34 million for area three targeting specific RNA viruses. Performance will take place at offeror facilities and clinical trial sites with deliverables including preclinical data, clinical trial results, and regulatory submissions stretching over one to five years.

Notice text

5 versions

Update #5 · Latest · Apr 8, 2022

AMENDMENT FOUR (4) - HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment Three is to provide the NIAID’s response to questions received regarding the solicitation. The responses are offered for information only and do not modify or become part of this solicitation. Additional amendments may be provided as needed to address further questions and their related responses.

_______________________________________________________________

AMENDMENT THREE (3) - HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment Three is to:

1. Update the “Date Offers Due” in Beta Sam to April 18, 2022, at 3:00pm EST for Research Areas 001, 002, and 004. Please note that the “Date Offers Due” for Research Area 003 remains unchanged as March 18, 2022, at 3:00pm EST;

2. Provide a cut-off date of April 1, 2022 for questions from potential offerors under Research Areas 001, 002, and 004; and

3. Provide the NIAID’s response to questions received regarding the solicitation. The responses are offered for information only and do not modify or become part of this solicitation. Additional amendments may be provided as needed to address further questions and their related responses.

_______________________________________________________________

AMENDMENT TWO (2) - HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment Two is to:

1. Provide a Sample Task Linked Budget as specified in Amendment 1, GENERAL QUESTIONS APPLICABLE TO ALL RESEARCH AREAS, Question 12.

2. Correct the cut-off date for questions from potential offerors under Research Area 003 to March 1, 2022.
_______________________________________________________________

AMENDMENT ONE (1) - HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment One is to:

1. Provide the NIAID’s response to questions received regarding the solicitation. The responses are offered for information only and do not modify or become part of this solicitation. Additional amendments may be provided as needed to address further questions and their related responses.

2. Provide a cut-off date of March 1, 2022 for questions from potential offerors under Research Area 003.
_______________________________________________________________

NIAID 2022 OMNIBUS BROAD AGENCY ANNOUNCEMENT (BAA) NO. HHS-NIH-NIAID-BAA2022-1 contains four (4) distinct Research Areas, each with a specified closing date and time. The proposal due date of March 18, 2022, specified in this solicitation posting, is the due date for Research Area 003 only. An Amendment will be issued at a later date to update the proposal due date for responses to Research Areas 001, 002, 004. The proposal due dates for each Research Area are identified below:

Research Area 001 - Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases

Proposals Due Date and Time - 3:00PM Eastern Time on April 18, 2022

Research Area 002 - Development of Therapeutic Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases

Proposals Due Date and Time - 3:00PM Eastern Time on April 18, 2022

Research Area 003 - The Antiviral Program for Pandemics (APP): Development of Antivirals for Specific RNA Viral Families of Pandemic Potential

Proposals Due Date and Time - 3:00PM Eastern Time on March 18, 2022

Research Area 004 - Development of In Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (AMR), and Emerging Infectious Diseases

Proposals Due Date and Time - 3:00PM Eastern Time on April 18, 2022

Update #4 · Mar 16, 2022

AMENDMENT THREE - HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment Three is to:

_______________________________________________________________

AMENDMENT TWO- HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment Two is to:

1. Provide a Sample Task Linked Budget as specified in Amendment 1, GENERAL QUESTIONS APPLICABLE TO ALL RESEARCH AREAS, Question 12.

2. Correct the cut-off date for questions from potential offerors under Research Area 003 to March 1, 2022.
_______________________________________________________________

AMENDMENT ONE - HHS-NIH-NIAID-BAA2022-1

The purpose of Amendment One is to:

1. Provide the NIAID’s response to questions received regarding the solicitation. The responses are offered for information only and do not modify or become part of this solicitation. Additional amendments may be provided as needed to address further questions and their related responses.

2. Provide a cut-off date of March 1, 2022 for questions from potential offerors under Research Area 003.
_______________________________________________________________